Top Markets
#1 Fake World Assets Fake World Assets +10.69%
#2 B3 (Base) B3 (Base) +10.34%
#3 Janction Janction +9.46%
#4 Verus Coin Verus Coin +7.95%
#5 TENDIES TENDIES +6.38%
#6 GoPlus Security GoPlus Security +4.67%
#7 龙虾 (Lobster) 龙虾 (Lobster) +4.03%
#8 Provenance Blockchain Provenance Blockchain +3.76%
#9 Everything Everything +3.72%
#10 OVERTAKE OVERTAKE +3.30%
Coin of the day
Fake World Assets Fake World Assets
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rang in aandelen #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Aandeelprijs
$0.617
Laatst gesynchroniseerd: 2024-10-14
Marktkapitalisatie
$6.13M
Verandering (1 dag)
0.49%
Verandering (1 jaar)
0.00%
Land
US
Handel Kineta, Inc. (KA)

Categorie

Healthcare
EPS voor Kineta, Inc. (KA)
EPS per March 2025 TTM: $-0.66
Volgens de laatste financiële rapporten en de aandelenkoers van Kineta, Inc. is de huidige EPS van het bedrijf (TTM) $-0.66. Eind 2023 had het bedrijf een EPS van $-1.28, een daling ten opzichte van de EPS van 2022 die $-12.80 bedroeg.
EPS-geschiedenis van Kineta, Inc. van 2015 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.66 -53.52%
2024 $-1.42 10.94%
2023 $-1.28 -90.00%
2022 $-12.80 57.25%
2021 $-8.14 -80.27%
2020 $-41.26 -74.51%
2019 $-161.86 -28.02%
2018 $-224.87 -31.33%
2017 $-327.48 17.86%
2016 $-277.86 97.27%
2015 $-140.85 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,724.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -4,303.03%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -2,175.77%
BE